title: Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications.
authors.forename: S R
authors.initials: SR
authors.lastname: Friedman
authors.forename: M A
authors.initials: MA
authors.lastname: Wainberg
authors.forename: E
authors.initials: E
authors.lastname: Drucker
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial / Q000235:genetics; D004359:Drug Therapy, Combination; D004992:Ethics, Medical; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D009154:Mutation / Q000187:drug effects; D010349:Patient Compliance; D012367:RNA, Viral / Q000097:blood; D012307:Risk Factors; D012661:Semen / Q000821:virology; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral